1 year return (CAGR)
1557.89%
Eloxx Pharmaceuticals, Inc. Exchange (NASDAQ, USD)
ELOX
17.63
-0.53 (-3.26%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-18.41%
5 year return (CAGR)
-40.16%
10 year return (CAGR)
-36.12%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
54.12M
Price/Sales
-
Ent value
9.13M
Price/Book
1.17
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-31.13%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 16.74 |
| Daily high | 17.19 |
| Daily low | 15.03 |
| Daily Volume | 17K |
| All-time high | 393600.00 |
| 1y analyst estimate | 40.33 |
| Beta | -160692.25 |
| EPS (TTM) | -2.00 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ELOX | S&P500 | |
| Current price drop from All-time high | -100.00% | -3.06% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 6 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -81.29% | -10.68% |
| Avg time to new high | 577 days | 12 days |
| Max time to new high | 5809 days | 1805 days |
News
